The Quantellect read.As of Nov 19, 2026, 12 active firms cover Repligen Corporation: 11 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $145.00 to $225.00, a moderate spread. The average target of $176.92 sits 2% above the current $172.65. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.60 next quarter toward $2.65 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Buy
Strong Buy00%
Buy1192%
Neutral18%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$176.92
+2.5% upside
Average target across 12 active firms as of Nov 19, 2026 vs $172.65 current
Highest Target$225.00
Average Target$176.92
Lowest Target$145.00
Detailed analyst forecasts for RGEN
Showing 1–12 of 12 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 11 of 12 active firms rate RGEN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
RGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.60
Range $0.53 – $0.67 · 10 analysts · +24% YoY
Next period, 10 analysts expect Repligen Corporation to earn $0.60 a share (range $0.53 – $0.67), versus $0.48 a year earlier. Full-year consensus is $2.07, growing to $2.65 the year after.
REVENUE · NEXT QUARTER
$250.3M
Range $245.6M – $252.7M · 10 analysts · +29% YoY
Revenue is expected to reach $250.3M (range $245.6M – $252.7M), +28.8% year-over-year. Full-year consensus is $848.8M, rising to $1.1B next year.
Top analysts covering Repligen Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RGEN.
#1
Puneet Souda
Leerink Partners · Rank #30
Buy
$200.00+15.8% to target
Overall win rate
57%
+ Follow
#2
KM
Kyle Mikson
Canaccord Genuity · Rank #202
Neutral
$145.00-16.0% to target
Overall win rate
40%
+ Follow
#3
Conor McNamara
RBC Capital · Rank #254
Buy
$204.00+18.2% to target
Overall win rate
34%
+ Follow
#4
Luke Sergott
Barclays · Rank #267
Buy
$225.00+30.3% to target
Overall win rate
43%
+ Follow
#5
RW
Robert Wasserman
Benchmark · Rank #388
Buy
$185.00+7.2% to target
Overall win rate
41%
+ Follow
RGEN stock forecast FAQ
What is RGEN's average 12-month price target?+
The 12 active firms with a live target average $176.92 for Repligen Corporation over the next 12 months, ranging from a $225.00 high to a $145.00 low, as of Nov 19, 2026.
Is RGEN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 12 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for RGEN?+
The Street-high target is $225.00 (Barclays), and the Street-low is $145.00 (Wolfe Research). The average of all 12 active-firm targets is $176.92.
How many active Wall Street firms cover RGEN?+
12 active firms have a recognized rating on Repligen Corporation as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering RGEN?+
Among analysts who currently cover RGEN, Puneet Souda of Leerink Partners has the strongest overall Quantellect track record (Rank #30). Their current call is Buy with a $200.00 target.
What is Repligen Corporation's projected EPS for next quarter?+
The consensus estimate is $0.60 per share (range $0.53 – $0.67) across 10 analysts. Full-year EPS is projected at $2.07, rising to $2.65 the following year.
How much revenue is Repligen Corporation expected to report next quarter?+
Consensus revenue is $250.3M (range $245.6M – $252.7M). Full-year revenue is projected at $848.8M, growing to $1.1B next year.
Have analysts been upgrading or downgrading RGEN lately?+
As of Nov 19, 2026, 11 of 12 active firms rate RGEN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.